Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Bioactive and Compatible Polymers
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kojima, Y.
Right arrow Articles by Maeda, H.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Evaluation of Poly(vinyl alcohol) for Protein Tailoring: Improvements in Pharmacokinetic Properties of Superoxide Dismutase

Yuichiro Kojima

Department of Microbiology Kumamoto University School of Medicine 2-2-1 Honjo, Kumamoto 860, Japan

Hiroshi Maeda

Department of Microbiology Kumamoto University School of Medicine 2-2-1 Honjo, Kumamoto 860, Japan

Conjugation of poly(vinyl alcohol) (PVA) containing a thiol group to superoxide dismutase (SOD) was performed by using N-(isin-maleimido caproyloxy)succinimide (EMCS) as a coupling agent. Various chemical charac teristics and pharmacokinetic parameters were evaluated. Two different molec ular weight PVA-SOD conjugates were prepared. Both retained at least 92% of the native SOD activity whereas the plasma half-life increased from 4.8 min for the native SOD to 3.0 and 7.8 h for the low and high molecular weight PVA conjugates, respectively. Tissue distribution studies revealed that in travenously administered PVA-SOD had a high concentration primarily in the circulation, followed by the kidney, the lung, the liver, and the spleen. Un modified SOD was rapidly excreted via the urine, with the exception of high retention in the kidney (36% of the injected dose). PVA-SOD was also rapidly ex creted in the urine, which suggests that the kidney is the main route of excre tion of the derivatives. PVA-SOD exhibited a lower antigenicity and immuno genicity and an enhanced therapeutic effect against ischemic edema of the mouse foot pad compared with the native form. PVA with a thiol functional group appears to be useful for the preparation of protein drug-polymer conju gates, with significant diminution of immunogenicity but retention of almost full biological activity attributable to both mild conjugation conditions and selective reaction.

Journal of Bioactive and Compatible Polymers, Vol. 8, No. 2, 115-131 (1993)
DOI: 10.1177/088391159300800202


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Journal of Bioactive and Compatible PolymersHome page
Y. Kojima, T. Akaike, K. Sato, H. Maeda, and T. Hirano
Polymer Conjugation to Cu,Zn-SOD and Suppression of Hydroxyl Radical Generation on Exposure to H2O2: Improved Stability of SOD in Vitro and in Vivo
Journal of Bioactive and Compatible Polymers, July 1, 1996; 11(3): 169 - 190.
[Abstract]